Alastair Gray

1953 -

occupation: health economist

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 123

Date

Title

Authors

2020-03-01

Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?

Ruth L Coleman, Alastair Gray, David Fitchett, Bernard Zinman, Rury Holman
2020-05-07

Which interactions matter in economic evaluations? A systematic review and simulation study

Helen Dakin, Alastair Gray
2020-07-02

Who gets referred for knee or hip replacement? A theoretical model of the potential impact of evidence-based referral thresholds using data from a retrospective review of clinic records from an English musculoskeletal referral hub

Helen Dakin, Peter Eibich, Alastair Gray, Andrew Price, David Beard
2019-01-28

Impact of Vision Loss on Health-Related Quality of Life in Trinidad and Tobago

Tasanee Braithwaite, Konrad Pesudovs, Alastair Gray, Samuel S. Ramsewak
2019-03-23

Surgical fixation with K-wires versus plaster casting in the treatment of dorsally displaced distal radius fractures: protocol for Distal Radius Acute Fracture Fixation Trial 2 (DRAFFT 2)

Jonathan A. Cook, Alastair Gray, Melina Dritsaki
2019-03-20

A critical integrative review of complementary medicine education research: key issues and empirical gaps

Alastair Gray, Amie Steel
2019

Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project

Andrew Turner, Alastair Gray, Cathie Sudlow
2019-09-12

Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis

Alastair Gray
2019-01-01

Cost-effectiveness analysis of a placebo-controlled randomized trial evaluating the effectiveness of arthroscopic subacromial decompression in patients with subacromial shoulder pain

Jonathan A. Cook, Alastair Gray
2019-10-28

Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial

Helen Campbell, Alastair Gray, Judith M Watson, Cath Jackson, Oliver Rivero-Arias, Henry C Kitchener
2019-07-21

Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs

Mi Jun Keng, José Leal, Alastair Gray, Borislava Mihaylova
2019-11-30

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

Anthony Kong, Hisham Mehanna, Alastair Gray
2019-06-01

The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling

Andrew Price, James Smith, Helen Dakin, Sujin Kang, Peter Eibich, Jonathan A. Cook, Alastair Gray, Kristina Harris, Robert Middleton, Elizabeth Gibbons, Elena Benedetto, Stephanie Smith, Jill Dawson, Raymond Fitzpatrick, Adrian Sayers, Laura Miller, Elsa Marques, Rachael Gooberman-Hill, Ashley Blom, Andrew Judge, Nigel K Arden, David Murray, Sion Glyn-Jones, Karen Barker, Andrew Carr, David Beard
2019-04-04

Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts

Matthew Little, Alastair Gray, Umberto Benedetto, Stephen Gerry, Jacqueline Murphy
2019-01-01

Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.

Umberto Benedetto, Stephen Gerry, Alastair Gray, Stephen Clark, Douglas G. Altman, Keith Channon, Andrzej Bochenek, Marek A Deja, Stanisław Woś
2018-12-19

Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study

Seamus Kent, Borislava Mihaylova, Benjamin Cairns, Alastair Gray, Valerie Beral, Gillian K Reeves, Susan Jebb
2018-01-01

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD)

May Ee Png, Alastair Gray, Rafael Pinedo-Villanueva, Oliver Rivero-Arias, Jagdeep Nanchahal, Melina Dritsaki
2018-08-13

Risk attitudes of people with 'manageable' chronic disease: An analysis under prospect theory

Arthur E. Attema, Alastair Gray
2018-10-25

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial

Michael A Nauck, Alastair Gray
2018-11-01

Knee replacement

Anders Troelsen, Gary Hooper, Alastair Gray
2018-04-09

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Lei Si, Xinyang Hua, Michael Willis, Christian Asseburg, Alastair Gray, Patrick O'Connor, Daniel Pollard, An Tran-Duy
2018-10-10

Simulating the impact of targeting lower systolic blood pressure and LDL-cholesterol levels on type 2 diabetes complication rates

Alastair Gray, Rury Holman
2018-08-28

Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level

Ines Rombach, Alastair Gray, Crispin Jenkinson
2018-02-13

Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial

Umberto Benedetto, Stephen Gerry, Alastair Gray, Keith Channon
2018-04-01

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Simon J. Griffin, Mary Angelyn Bethel, Rury Holman, Nicholas J. Wareham, Melanie Davies, Andrew Dymond, Philip Evans, Alastair Gray, Colin J. Greaves, Kamlesh Khunti
2018-03-03

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).

Stephen Gerry, Douglas G. Altman, Alastair Gray, Umberto Benedetto, Keith Channon
2018-06-21

Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials

Ines Rombach, Alastair Gray
2018-08-16

Partial factorial trials: comparing methods for statistical analysis and economic evaluation

Helen Dakin, Alastair Gray, Richard W. Morris, Graeme MacLennan
2018-01-23

Resource utilisation and costs in predementia and dementia: a systematic review protocol.

Ron Handels, Isaac Ghinai, Alastair Gray
2018-01-25

What do we know about managing Dupuytren's disease cost-effectively?

Oliver Rivero-Arias, Alastair Gray, Melina Dritsaki
2018-04-20

Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Shelby D Reed, Alastair Gray, Rury Holman, Eric D. Peterson
2018-03-30

Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol.

Alastair Gray, Isaac Ghinai, Jane L Wolstenholme, Ron Handels

Human - wd:Q47443039

Welcome to Inventaire

the library of your friends and communities

learn more